← Leaderboards
Xi Lin
House Ear Institute
$11,105,959
Attributed
$11,938,016
Total exposure
16
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2005–19$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$11,938,016 · 16
By mechanism
R01$8,799,653 · 4
R33$2,032,093 · 1
R21$1,046,032 · 4
P41$60,238 · 7
Top collaborators
- Keqiang Ye6 shared
Most similar at House Ear Institute
Same institution · by research overlap
- Yvonne S Sininger$4,052,868
- Manuel Don$2,657,624
Others in their field
Top investigators on “Mutation”
- Richard A Gibbs · Baylor College Of Medicine$276,143,183
- David Heimbrook · Leidos Biomedical Research, Inc.$175,834,894
- Randall J Bateman · Washington University$154,391,630
- Eric Martin McDade · Washington University$96,219,353
- Stacey Gabriel · Massachusetts Institute Of Technology$95,141,374
- Tatiana M. Foroud · Indiana Univ-Purdue Univ At Indianapolis$93,475,056
Research focus
MutationDeafnessGrantPublishingHearing ImpairmentHearingGenesCochlear StructureGeneticBaseIn VitroCouplingDesignMediatingMouse ModelAffectConnexinsHair CellsIn VivoPropertyHearing Impaired PersonsInheritedStructureMolecular
Grant awards (43)
Gene Therapy for Treating Human Genetic Deafness Tested in Animal Models$481,848
R01 · FY2019 · DC · contact PI
Hearing Restoration by Virally Expressing Mechano-Sensitive Channels in Spiral Ganglion Neurons$234,000
R21 · FY2019 · DC · contact PI
Gene Therapy for Treating Human Genetic Deafness Tested in Animal Models$481,848
R01 · FY2018 · DC · contact PI
Gene Therapy for Treating Human Genetic Deafness Tested in Animal Models$481,848
R01 · FY2017 · DC · contact PI
Gene Therapy for Treating Human Genetic Deafness Tested in Animal Models$481,848
R01 · FY2016 · DC · contact PI
Role of connexins in cochlear functions$339,359
R01 · FY2015 · DC · contact PI
Role of connexins in cochlear functions$342,787
R01 · FY2014 · DC · contact PI
Genetic hearing screening and diagnosis facilitated by using a combined low-cost$400,274
R33 · FY2013 · DC · contact PI
Role of connexins in cochlear functions$325,648
R01 · FY2013 · DC · contact PI
Auditory Neuroprotection by Small Molecule Agonists of the TrkB Receptor$299,865
R01 · FY2013 · DC · contact PI
Genetic hearing screening and diagnosis facilitated by using a combined low-cost$533,429
R33 · FY2012 · DC · contact PI
Role of connexins in cochlear functions$342,787
R01 · FY2012 · DC · contact PI
Auditory Neuroprotection by Small Molecule Agonists of the TrkB Receptor$315,647
R01 · FY2012 · DC · contact PI
Genetic hearing screening and diagnosis facilitated by using a combined low-cost$536,603
R33 · FY2011 · DC · contact PI
Role of connexins in cochlear functions$342,787
R01 · FY2011 · DC · contact PI
Auditory Neuroprotection by Small Molecule Agonists of the TrkB Receptor$315,647
R01 · FY2011 · DC · contact PI
PHYTOSTEROL GLYCOSIDES REDUCE CHOLESTEROL ABSORPTION IN HUMANS$8,547
P41 · FY2011 · RR · contact PI
D- CHIRO-INOSITOL IS ABSORBED BUT NOT SYNTHESISED IN RODENTS$7,877
P41 · FY2011 · RR · contact PI
HUMAN SODIUM/INOSITOL COTRANSPORTER 2 (SMIT2) TRANSPORTS INOSITOLS$7,207
P41 · FY2011 · RR · contact PI
Genetic hearing screening and diagnosis facilitated by using a combined low-cost$561,787
R33 · FY2010 · DC · contact PI
Role of connexins in cochlear functions$335,173
R01 · FY2010 · DC · contact PI
Auditory Neuroprotection by Small Molecule Agonists of the TrkB Receptor$326,081
R01 · FY2010 · DC · contact PI
Auditory Neuroprotection by Small Molecule Agonists of the TrkB Receptor$77,500
R01 · FY2010 · DC · contact PI
HUMAN SODIUM/INOSITOL COTRANSPORTER 2 (SMIT2) TRANSPORTS INOSITOLS$11,261
P41 · FY2010 · RR · contact PI
D- CHIRO-INOSITOL IS ABSORBED BUT NOT SYNTHESISED IN RODENTS$11,261
P41 · FY2010 · RR · contact PI
PHYTOSTEROL GLYCOSIDES REDUCE CHOLESTEROL ABSORPTION IN HUMANS$11,261
P41 · FY2010 · RR · contact PI
Auditory Neuroprotection by Small Molecule Agonists of the TrkB Receptor$329,375
R01 · FY2009 · DC · contact PI
Role of connexins in cochlear functions$328,701
R01 · FY2009 · DC · contact PI
Genetic hearing screening and diagnosis facilitated by using a combined low-cost$224,222
R21 · FY2009 · DC · contact PI
Role of connexins in cochlear functions$43,358
R01 · FY2009 · DC · contact PI
Role of connexins in cochlear functions$319,123
R01 · FY2008 · DC · contact PI
Mouse models for human deafness caused by diverse types of connexin26 mutations$192,091
R21 · FY2008 · DC · contact PI
Role of connexins in cochlear functions$332,046
R01 · FY2007 · DC · contact PI
Mouse models for human deafness caused by diverse types of connexin26 mutations$247,014
R21 · FY2007 · DC · contact PI
A TARGETED APOB389 MUTATION IN MICE IS ASSOCIATED WITH REDUCED HEPATIC$2,824
P41 · FY2007 · RR · contact PI
Role of connexins in cochlear functions$332,002
R01 · FY2006 · DC · contact PI
MOLECULAR MECHANISMS OF THE COCHLEAR EFFERENT FUNCTIONS$382,500
R01 · FY2005 · DC
MOLECULAR MECHANISMS OF THE COCHLEAR EFFERENT FUNCTIONS$382,500
R01 · FY2004 · DC
MOLECULAR MECHANISMS OF THE COCHLEAR EFFERENT FUNCTIONS$373,750
R01 · FY2003 · DC
MOLECULAR MECHANISMS OF THE COCHLEAR EFFERENT FUNCTIONS$349,000
R01 · FY2002 · DC
MOLECULAR MECHANISMS OF THE COCHLEAR EFFERENT FUNCTIONS$336,625
R01 · FY2001 · DC
METHODS FOR RECORDING COCHLEAR NEUROTRANSMISSION IN SITU$78,650
R21 · FY2001 · DC
METHODS FOR RECORDING COCHLEAR NEUROTRANSMISSION IN SITU$70,055
R21 · FY2000 · DC